Skip to Main Content

Paper Details

Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.
Crit Care Med
81
2016
MOF, PERSEVERE, PERSEVERE-II, Septic Shock, TAMOF, children, patients, pediatric septic shock, platelet, septic shock, thrombocytopenia, thrombocytopenia-associated multiple organ failure
Biomarkers, Chemokine CCL3, Child, Child, Preschool, Female, Granzymes, HSP70 Heat-Shock Proteins, Humans, Infant, Intensive Care Units, Pediatric, Interleukin-8, Male, Matrix Metalloproteinase 8, Models, Statistical, Multiple Organ Failure, Platelet Count, Prognosis, Risk Assessment, Shock, Septic, Thrombocytopenia, United States
Author NameAffiliation
Hector R WongCincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine, OH. 3UCSF Benioff Children's Hospital Oakland, CA. 4Children's Hospital of Orange County, CA. 5Children's Mercy Hospital, MO. 6Penn State Hershey Children's Hospital, PA. 7Akron Children's Hospital, OH. 8The Children's Hospital of Philadelphia, PA. 9Texas Children's Hospital and Baylor College of Medicine, TX. 10Miami Children's Hospital, FL. 11CS Mott Children's Hospital at the University of Michigan, MI. 12Nationwide Children's Hospital, OH. 13Children's Hospital of Wisconsin, WI. 14Children's National Medical Center, DC. 15Children's Hospital and Clinics of Minnesota, MN. 16Riley Hospital for Children, IN. 17Hackensack University Medical Center, Joseph M. Sanzari Children's Hospital
  • 1 - 1

Datasets

Release 1.2